Element Capital Management’s AngioDynamics ANGO Stock Holding History

Element Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,523	Closed	-$286K	–	273
2019 Q1	$286K	Buy	+12,523	New	+$272K	0.01%	608
2018 Q4	–	Sell	-13,992	Closed	-$304K	–	649
2018 Q3	$304K	Buy	+13,992	New	+$311K	0.01%	591
2018 Q2	–	Sell	-12,571	Closed	-$217K	–	817
2018 Q1	$217K	Buy	+12,571	New	+$210K	0.01%	635

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Element Capital Management's ANGO Position: Q2 2019 in Review

Element Capital Management sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 12,523 shares — an estimated $286K sold.

Element Capital Management first reported a position in ANGO in Q1 2018 and held it in 3 quarters. The position peaked at $304K in Q3 2018. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

Element Capital Management reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 12,523 AngioDynamics shares in Q2 2019, an estimated $286K.
Element Capital Management first reported a position in AngioDynamics in Q1 2018 and held it in 3 quarters.
Element Capital Management's AngioDynamics position peaked at $304K in Q3 2018.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.